The U.S. Federal government committed $4.5 billion dollars to the BRAIN initiative, because deciphering complex neural circuits underlying mental disorders such as schizophrenia and depression is key to developing targeted therapies. Available treatments for these disorders lack specificity and therefore cause severe side effects in patients. Retrograde transcellular viral tracers are powerful tools for mapping the inputs to specific neuronal populations in brain circuits. However, anterograde viral tracers for identifying target neurons downstream of synaptic outputs remain under-developed.
USC scientists have demonstrated that anterograde transport of adeno-associative virus (AAV) from pre-synaptic neurons can effectively and specifically drive transgene expression in postsynaptic neurons. This technique allows identification and manipulation of second-order neuronal projections in the brain.
由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。
developing targeted therapies
disorders lack specificity
severe side effects
specific neuronal populations
second-order neuronal projections